Lung cancer is the most common cause of cancer deaths worldwide, and lung
adenocarcinoma (LUAD) is the most common histological subtype. However, the prognostic …

Background Lung adenocarcinomas (LUAD) is the most common histological subtype of
lung cancers. Tumor immune microenvironment (TIME) is involved in tumorigeneses …

The tumor microenvironment (TME) is a vital component of tumor tissue. Increasing
evidence suggests their significance in predicting outcomes and guiding therapies …

Intertumoral immune heterogeneity is a critical reason for distinct clinical benefits of
immunotherapy in lung adenocarcinoma (LUAD). Tumor immunophenotype (immune 'Hot'or …

Lung adenocarcinoma (LUAD) is a devastating disease with poor patient survival. Cancer
immunotherapy has revolutionized the treatment of LUAD, but only a limited number of …

Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) are the two
major subtypes of lung cancer, with LUSC exhibits faster progression rate than LUAD. To …

Background Lung cancer has become the most common cancer type and caused the most
cancer deaths. Lung adenocarcinoma (LUAD) is one of the major type of lung cancer. This …

The existence of tumor heterogeneity and complex carcinogenic mechanisms in lung
adenocarcinoma (LUAD) make the most commonly used TNM staging system unable to well …

Background Lung adenocarcinoma (LUAD) contains a variety of genomic and epigenomic
abnormalities; the effective tumor markers related to these abnormalities need to be further …

Lung adenocarcinoma is one of the most common malignant tumors worldwide. The
purpose of this study was to construct a stable immune gene signature for prediction of …